Prolactin Releasing Peptide (12-31), rat | Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | C104H158N32O26 |
proPT18 | His-Val-Phe-Leu-Ala-Pro-Gln-Gln-Ala-Arg-Ser-Leu-Leu-Gln-Arg-Val-Arg-Arg | C96H163N35O23 |
proPT28 | His-Val-Phe-Leu-Ala-Pro-Gln-Gln-Ala-Arg-Ser-Leu-Leu-Gln-Arg-Val-Arg-Arg-Ala-Asn-Thr-Phe-Leu-Glu-Glu-Val-Arg-Lys | C149H248N50O39 |
Prosaptide 769P | Cys-D-Ala-Phe-Leu-Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | C114H194N28O35S |
Prosaptide TX14(A) | Thr-D-Ala-Leu-Ile-Asp-Asn-Asn-Ala-Thr-Glu-Glu-Ile-Leu-Tyr | C69H110N16O26 |
Prosaptide, wild type | Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | C72H127N19O25 |
Protease - Activated Receptor - 2, PAR - 2 Agonist, amide | Ser-Leu-Ile-Gly-Lys-Val-NH2 | C28H54N8O7 |
Protein Kinase A Substrate | Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg | C34H64N14O11 |
Protein Kinase C (19-31) | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val | C67H118N26O16 |
Protein Kinase C (19-36); Protein Kinase C Selective Inhibitor Protein | Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | C93H159N35O24 |
Protein Kinase C (530-558) | Leu-Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Ala-Pro-Phe-Glu-Gly-Glu-Asp-Glu-Asp-Glu-Leu-Phe-Gln-Ser-Ile-Met-Glu-His-Asn-Val-NH2 | C148H220N34O51S2 |
Protein Kinase C Substrate | Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu | C51H100N22O11 |
Protein Kinase C substrate from EGF Receptor | Lys-Arg-Thr-Leu-Arg-Arg | C34H68N16O8 |
Protein Kinase C Substrate, Glycogen Synthase (1-8) | Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys-NH2 | C56H104N18O15 |
Protein Kinase G Substrate; G-Subtide | Gln-Lys-Arg-Pro-Arg-Arg-Lys-Asp-Thr-Pro | |
Protein Kinase p34(cd2) Substrate; CSH 103 | Ala-Asp-Ala-Gln-His-Ala-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-Lys-Asp-Phe | C106H172N32O32 |
Pro-TGF-a | His-Ala-Asp-Leu-Leu-Ala-Val-Val-Ala-Ala-Ser-Gln | C52H87N15O17 |
PRRS-PQGAB-C | Gly-Thr-Asp-Trp-Leu-Ala-Asn-Lys-Phe-Asp-Trp-Ala | C67H90N16O19 |
PRRS-PQGAB-M | Thr-Tyr-Ala-Ser-Asn-Asp-Ser-Ser-Ser-His-Leu-Gln | C53H80N16O23 |
PRRS-PQGAB-N | Gly-Ser-Ser-Leu-Asp-Asp-Phe-Cys-Tyr-Asp-Ser-Thr | C54H76N12O24S |
PRRS-RSAB-C | Leu-Asn-Gly-Thr-Asp-Trp-Leu-Ser-Asn-His-Phe-Asp-Trp-Ala | C77H102N20O23 |
PRRS-RSAB-N | Ala-Gly-Gly-Ser-Ser-Ser-Thr-Tyr-Gln-Tyr | C43H61N11O18 |
PT-141 | Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys Asp-Lys | C50H68N14O10 |
pTH (13-34) (human) | Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | C125H199N39O33S |
pTH (28-48) (human) | Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser | C95H150N28O29 |
Pyr-Gly-Arg-pNA | Pyr-Gly-Arg-pNA | C19H26N8O6 |
Q-K-R-P-S-Q-R-S-K-Y-L | Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | C60H103N21O17 |
Ranamargarin | Asp-Asp-Ala-Ser-Asp-Arg-Ala-Lys-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | C70H110N20O22S |
R-E-D-V | Arg-Glu-Asp-Val | C20H35N7O9 |
RES-701-1 | Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp | C103H117N23O24 |
RES-701-3 | Gly-Asn-Trp-His-Gly-Thr-Ser-Pro-Asp-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp | C103H117N23O25 |
RF-amide peptide, Drosophila | Thr-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 | C58H86N16O15 |
RF-amide, Chicken | Leu-Pro-Leu-Arg-Phe-NH2 | C32H53N9O5 |
R-G-D-S-P-A-S-S-K-P | Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro | C40H68N14O16 |
R-G-D-T | Arg-Gly-Asp-Thr | C16H29N7O8 |
R-JAG (188 - 206) R - Jagged - 1(188 - 206), Notch Ligand | Cys-Asp-Asp-Tyr-Tyr-Tyr-Gly-Phe-Gly-Cys-Asn-Lys-Phe-Gly-Arg-Pro-Arg-Asp-Asp | C100H135N27O32S2 |
RK9, p17 Gag (20 - 28) | Arg-Leu-Arg-Pro-Gly-Gly-Lys-Lys-Lys | C45H86N18O10 |
Rnase (90–105) | Ser-Lys-Tyr-Pro-Asn-Cys-Ala-Tyr-Lys-Thr-Thr-Gln-Ala-Asn-Lys-His | C80H124N24O25S |
RS domain derived peptide | Gly-Arg-Ser-Arg-Ser-Arg-Ser-Arg-Ser-Arg | C44H85N25O15 |
RSK Substrate, S6 (231-239) | Arg-Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala-NH2 | C45H88N22O11 |
RSV M (187 - 195) | Asn-Ala-Ile-Thr-Asn-Ala-Lys-Ile-Ile | C42H76N12O13 |
SALMF amide 1 (S1) | Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2 | C41H60N10O10S1 |
SALMF amide 2 (S2) | Ser-Gly-Pro-Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2 | C59H82N14O18 |
Salusin – β | Ala-Ile-Phe-Ile-Phe-Ile-Arg-Trp-Leu-Leu-Lys-Leu-Gly-His-His-Gly-Arg-Ala-Pro-Pro | C115H176N32O21 |
Salusin –α | Ser-Gly-Ala-Leu-Pro-Pro-Ala-Pro-Ala-Ala-Pro-Arg-Pro-Ala-Leu-Arg-Ala-Gln-Arg-Ala-Gly-Pro-Ala-Gly-Pro-Gly-Ala-Lys-NH2 | C114H192N40O30 |
Saposin C12 | Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | C62H108N16O22 |
Saposin C18 | Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | C93H164N24O31 |
Saposin C22 | Cys-Glu-Phe-Leu-Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | C116H196N28O37S |
Sarafotoxin S6c | Cys-Thr-Cys-Asn-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp | C103H151N27O37S5 |
Sarafotoxin S6d | Cys-Thr-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-Leu-Tyr-Phe-Cys-His-Gln-Asp-Ile-Ile-Trp | C112H167N27O34S5 |
Schizophrenia Related Peptide | Thr-Val-Leu | C15H29N3 |
Scrambled TRAP Fragment | Phe-Ser-Leu-Leu-Arg-Asn-NH2 | C34H57N11O8 |
Scyliorhinin I, amide, dogfish | Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | C59H87N13O13S |
Scyliorhinin I, Scy I; Shark Substance P Related Peptide | Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met | C59H86N12O14S |
Scyliorhinin II, amide ,dogfish | Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH2 (Disulfide bridge Cys7-Cys13 ) | C77H119N21O26S3 |
Secretin (5 - 27), porcine | Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-nh2 | C115H200N38O34 |
Sendai Virus Nucleoprotein (321-336) | His-Gly-Glu-Phe-Ala-Pro-Gly-Asn-Tyr-Pro-Ala-Leu-Trp-Ser-Tyr-Ala | C85H110N20O23 |
Sendai Virus Nucleoprotein (SV9), 324 – 332 | Phe-Ala-Pro-Gly-Asn-Tyr-Pro-Ala-Leu | C46H64N10O12 |
SEQ ID NO:549 | Phe-Leu-Gly-Lys-Ile-Trp-Pro-Ser-Tyr-Lys | C63H91N13O13 |
Ser-Ala-SAP-IIB | Ser-Ala-Lys-Leu-Cys-Pro-Gly-Gly-Asn-Cys-Val (Disulfide bond) | C42H71N13O14S2 |
SH2 Domain Ligand (1) | Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | C36H56N7O13PS |
SH2 Domain Ligand (2) | Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu | C66H97N12O24P |
SH2 Domain Ligand (3) | Biotin-LC-Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu | C82H122N15O27PS |
SH2 Domain Ligand (4) | Ac-pTyr-Tyr-pTyr-Ile-Glu | C40H51N5O18P2 |
SH2 Domain Ligand (5) | BiotinLC-Tyr(PO3H2)-Glu-Glu-Ile | C41H62N7O16PS |
sHNG, [Gly14] - HN, [Gly14] – Humanin | Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | C118H202N34O31S2 |
Sialokinin – 2 | Asp-Thr-Gly-Asp-Lys-Phe-Tyr-Gly-Leu-Met-nh2 | C51H76N12O16S |
S-I-G-S-L-A-K | Ser-Ile-Gly-Ser-Leu-Ala-Lys | C29H54N8O10 |
Simian Virus 40 Large Tumor
Antigen Amino-Terminal
Peptide | AC-Met-Asp-Arg-Val-Leu-Ser-Arg-Tyr | C46H76N14O14S |
SIVmac251 (gp140) Fragment (171-190) [Cys] | Lys-Phe-Thr-Met-Thr-Gly-Leu-Lys-Arg-Asp-Lys-Thr-Lys-Glu-Tyr-Asn-Glu-Thr-Trp-Tyr-Cys | C118H180N30O35S2 |
SKIGKV - NH2 | Ser-Lys-Ile-Gly-Lys-Val-NH2 | C28H55N9O7 |
SL9, HIV - 1 p17 (77 - 85) | Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu | C44H72N10O15 |
SMAP 29, Sheep Myeloid Antimicrobial Peptide 29 | Arg-Gly-Leu-Arg-Arg-Leu-Gly-Arg-Lys-Ile-Ala-His-Gly-Val-Lys-Lys-Tyr-Gly-Pro-Thr-Val-Leu-Arg-Ile-Ile-Arg-Ile-Ala-Gly | C146H260N52O32 |
SMCX (963-973) (human) | Ser-Pro-Ala-Val-Asp-Lys-Ala-Gln-Ala-Glu-Leu | C48H81N13O18 |
SMCY (950-960) (human) | Ser-Pro-Ser-Val-Asp-Lys-Ala-Arg-Ala-Glu-Leu | C49H85N15O18 |
Sodefrin | Ser-Ile-Pro-Ser-Lys-Asp-Ala-Leu-Leu-Lys | C48H86N12O15 |
Somatostatin Tumor Inhibiting Analog | D-ß-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bridge Cys2-Cys7 ) | C54H70N11O10S2 |
Somatostatin-14 (2-9) | Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys | C50H67N12O10S |
Somatostatin-14 (3-10) | Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr | C52H72N12O11S |
Somatostatin-14 (3-14) | Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bond) | C71H96N16O17S2 |
Somatostatin-14 (7-14) | Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys | C49H66N10O12S |
Somatostatin-14 (reduced) | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys | C76H106N18O19S2 |
SP1 | Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly | C72H97N17O19 |
SP2 | Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly-Lys | C78H109N19O20 |
SRC - 1 (682–697) | Ser-Leu-Thr-Ala-Arg-His-Lys-Ile-Leu-His-Arg-Leu-Leu-Gln-Glu-Gly | C82H142N28O22 |
SRC Kinase Substrate | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly | C64H107N22O24P |
SRC Kinase Substrate, amide | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly-NH2 | C64H108N23O23P |
STAL – 2 | Ser-Phe-Leu-Leu-Arg-Asn-NH2 | C34H57N11O8 |
Staphylococcal Alpha - Toxin P 1 | Lys-Thr-Gly-Asp-Leu-Val-Thr-Tyr-Asp-Lys-Glu-Asn-Gly | C61H98N16O24 |
Steroid Receptor Co - Factor Peptide | Leu-Thr-Glu-Arg-His-Lys-Ile-Leu-His-Arg-Leu-Leu-Gln-Glu | C79H136N26O21 |
Sturgeon F | Phe-Gly-Gly-Phe-Met-Lys-Gly-Lys-Tyr-Gly-Tyr | C61H83N13O14S |
Substance P (2-11)/Deca-Substance P | Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | C57H86N14O12S |
Substance P (3-11)/Nona-Substance P | Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | C52H79N13O11S |
Substance P (4-11)/Octa-Substance P | Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | C46H67N11O10S |
Substance P (5-11)/Hepta-Substance P | Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | C41H60N10O9S |
Substance P (6-11)/Hexa-Substance P | Gln-Phe-Phe-Gly-Leu-Met-NH2 | C36H52N8O7S |
Substance P (9-11) | Gly-Leu-Met-NH2 | C13H26N4O3S |
Substance P reversed sequence | Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg-NH2 | C63H98N18O13S |
Substance P-Gly-Lys-Arg | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg | C77H124N24O17S |
Substance P-methyl ester | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Ome | C64H99N17O14S |
Suc-APA-pNA | Suc-Ala-Pro-Ala-pNA | C21H27N5O8 |
Succinyl-(Glu9,Ala11,15)-Endothelin-1 (8-21) | Suc-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | C86H118N17O27 |
Suc-LEPF-pNA | Suc-Leu-Glu-Pro-Phe-pNA | C35H44N6O11 |
Suc-RGPF-pNA | Suc-Arg-Gly-Pro-Phe-pNA | C32H41N9O9 |
Suc-SDPF-pNA | Sue-Ser-Asp-Pro-Phe-pNA | C31H36N6O12 |
SV40 NLS | Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly | C42H81N15O9 |
SV40 Nuclear Transport Signal Peptide Analog | Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly | C60H104N20O15S |
Synapsin I - derived peptide | Leu-Arg-Arg-Arg-Leu-Ser-Asp-Ala-Asn-Phe-NH2 | C53H91N21O14 |
Synaptobrevin-2 (73-79) (human, bovine, mouse, rat) | Ala-Ser-Gln-Phe-Glu-Thr-Ser | C32H48N8O14 |
Synaptobrevin-2 (75-78) (human, bovine, mouse, rat) | Gln-Phe-Glu-Thr | C23H33N5O9 |
TA-0910, taltirelin | 1-methyl-4,5-dihydroorotyl-His-Pro-NH2 | C17H23N7O5 |
TACE (ADAM-17) | Mca-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Lys(Dnp)-NH2 | C75H115N24O26 |
Tachykinin (111-129) Beta-Prepro (Human) | Ala-Leu-Asn-Ser-Val-Ala-Tyr-Glu-Arg-Ser-Ala-Met-Gln-Asn-Tyr-Glu-Arg-Arg-Arg | C96H156N34O31S |
Tax8, HTLV - 1 (12 - 19) | Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val | C50H68N8O11 |
Tax9, HTLV - 1 (11 - 19) | Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val | C56H79N9O12 |
TET 830 modified/T - helper epitope from tetanus toxoid | Ala-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu | C83H134N20O24 |
Tetanus toxin (TT) peptide | Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Phe-Glu | C79H120N18O21 |
TGF a (34-43) (rat) | Cys-His-Ser-Gly-Tyr-Val-Gly-Val-Arg-Cys (Disulfide bridge:Cys1-Cys10) | C44H67N15O13S2 |
TNF - α (31 - 45), human | Arg-Arg-Ala-Asn-Ala-Leu-Leu-Ala-Asn-Gly-Val-Glu-Leu-Arg-Asp | C69H122N26O22 |
TNF - α (72 - 82), human | Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | C48H86N18O16 |
TNF-a (46-65) (human) | Asn-Gln-Leu-Val-Val-Pro-Ser-Glu-Gly-Leu-Tyr-Leu-Ile-Tyr-Ser-Gln-Val-Leu-Phe-Lys | C110H172N24O30 |
TNF-α(10-36) (human) | Asp-Lys-Pro-Val-Ala-His-Val-Val-Ala-Asn-Pro-Gln-Ala-Glu-Gly-Gln-Leu-Gln-Trp-Leu-Asn-Arg-Arg-Ala-Asn-Ala-Leu | C131H211N43O38 |
TNF-α(71-82), human | Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | C51H91N19O18 |
TNF-α(78-96) (human) | His-Thr-Ile-Ser-Arg-Ile-Ala-Val-Ser-Tyr-Gln-Thr-Lys-Val-Asn-Leu-Leu-Ser-Ala | C93H157N27O28 |
Transduction Peptide 1 (α II) | Ser-Ser-Leu-Thr-Ser-Arg-Asp-Phe-Gly-Ser-Trp-Tyr-Ala-Ser-Arg | C75H110N22O25 |
Transforming Growth Factor
ß1 Peptide, TGF - ß1 (60 - 66),
amide | Lys-Val-Leu-Ala-Leu-Tyr-Asn-Lys-NH2 | C45H78N12O10 |
Transglutaminase Substrate, biotinylated | BiotinThr-Val-Gln-Gln-Glu-Leu | C40H66N10O14S |
TRAP-14 | Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe | C81H118N20O23 |
TRAP-14 amide | Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH2 | C81H119N21O22 |
TRAP-5 amide | Ser-Phe-Leu-Leu-Arg-NH2 | C30H51N9O6 |
TRAP-6 (2-6) | Phe-Leu-Leu-Arg-Asn | C31H51N9O7 |
TRH | Pyr-His-Pro-NH2 | C16H22N6O4 |
TRH-AMC | Pyr-His-Pro-AMC | C26H28N8O4 |
TRH-Gly | Pyr-His-Pro-Gly | C18H24N6O6 |
TRH-SH Pro | Cys-Lys-Arg-Gln-His-Pro-Gly-Lys-Arg-Cys | C48H85N21O12S2 |
Tryptophan Motif Peptide | Gly-Gly-Trp-Ser-His-Trp-NH2 | C35H41N11O7 |
Type B Allatostatin | Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH2 | C104H150N24O27 |
Tyr-ACTH (4-9) | Tyr-Met-Glu-His-Phe-Arg-Trp | C51H65N13O11S |
Tyr-Amyloid P Component (27-38) amide | Tyr-Glu-Lys-Pro-Leu-Gln-Asn-Phe-Thr-Leu-Cys-Phe-Arg-NH2 | C77H116N20O19S |
Tyr-Bradykinin | Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | C59H82N16O13 |
Tyr-Leptin (26-39) (human) | Tyr-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val | C80H137N19O25 |
Tyrosinase (192-200) (human, mouse) | Ser-Glu-Ile-Trp-Arg-Asp-Ile-Asp-Phe | C54H77N13O17 |
Tyrosinase (206-214) (human) | Ala-Phe-Leu-Pro-Trp-His-Arg-Leu-Phe | C61H83N15O10 |
Tyrosinase (243-251) (human) | Lys-Cys-Asp-Ile-Cys-Thr-Asp-Glu-Tyr | C44H68N10O18S2 |
Tyrosine Kinase Peptide 3
[RRLIEDAE-pY-AARG],
Acetylated, Amide,
Phosphorylated | Ac-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly-NH2 | C66H110N23O24P |
Tyr-PDGF A-Chain (194-211) | Tyr-Gly-Arg-Pro-Arg-Glu-Ser-Gly-Lys-Lys-Arg-Lys-Arg-Lys-Arg-Leu-Lys-Pro-Thr | C101H181N39O25 |
Tyr-Somatostatin-14 | Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge: Cys4-Cys15) | C85H113N19O21S2 |
Universal TT epitope P2 (830-844) | Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu | C80H129N19O23 |
Urechistachykinin I | Leu-Arg-Gln-Ser-Gln-Phe-Val-Gly-Ser-Arg-NH2 | C50H85N19O14 |
Uremic Pentapeptide (U5-Peptide) | Asp-Leu-Trp-Gln-Lys | C32H48N8 |
